Félicitations au Pr Gilbert LENOIR pour son élection au Board de l'UICC

gilbert1

BIOGRAPHY

Gilbert Lenoir is Professor of Medical genetics. He is a Board Member (since 1998) and past President (2010-2012) of the “Ligue Française contre le Cancer” (the major French Cancer charity). He has dedicated his entire career to cancer. A scientist at the Interna-tional Agency for Research on Cancer (IARC – Lyon, France), and professor at the medical school, he was appointed as Deputy Director in charge of research at the Institut Gustave Roussy, Villejuif in 2000. Since 2010 he has been in charge of the Paris biocluster programme: Cancer Campus. He is the author of more than 400 articles in cancer genetics, epidemiological and translational research.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

My experience has been mainly research involving international collaborations: basic and translational, epidemiology always implicating public health issues. I am also a professor, a teacher and I have always participated in education programmes. My first20 years of professional experience was done at IARC in Lyon France: Burkitt’s lymphoma in central and North Africa,nasopharyngeal carcinoma in South East Asia. My basic research also required international collaborations mainly between European and North American teams. In 1985, I initiated international projects aimed at studying genetic susceptibility to cancer and then the International Consortium on breast cancer which leads to the identificationof the susceptibility genes. As director of research at IGR, we mainly launched European projects on translational research.As Board Member and President of the French Cancer Ligue, we reinforced our participation with UICC, to the European Cancer Ligue association and created the “Alliance des Ligues francophones, Africaines et Méditerranéennes” (ALIAM).My priority areas are: - Prevention: UICC representing the fieldof cancer must be at the forefront in the fieldof NCD’s, developing and implementing key measures. Tobacco control is a priority. We must support an ambitious programme on tobacco control and the implementation of a tobacco solidarity levy to finance it- Treatment: UICC must improve access to treatment worldwide by: training professionals where it’s needed, improving access to equipment, negotiating with companies for a better access to drugs.- Impact of UICC: Reinforcing the mobilisation against cancer in low and middle HDI countries including Mediterranean and African French speaking countries.

Etats-Unis: Dr Felicia KNAUL

Elections-UICC Felicia-Knaul


BIOGRAPHY

Felicia M. Knaul is a cancer survivor and an academic with over 130 publications. She is Associate Professor at Harvard Medical School, Director of the Harvard Global Equity Initiative, and co-Director of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. She lead authored the report “Closing the Cancer Divide”. She is also Senior Economist at the Mexican Health Foundation with extensive experience in designing and evaluating healthcare systems. Felicia founded the Mexican non-profit Cáncer de Mama:Tómatelo a Pecho to promote research and advocacy in Latin America, and published a testimonial book.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

I will bring extensive research and policy experience in global health and cancer. My skills as a health economist, health systems practitioner, advocate and policy advisor in various contexts are of particular relevance to the UICC Board of Directors.My contributions to UICC have always sought to forge links between health systems experts, broader organisations working on health systems and UICC to promote relevant institutional partnerships globally, i.e. linking efforts of the WHO-ADG for Family, Women’s and Children’s Health with that of UICC. The Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries (GTF.CCC), which I co-directed, has been most appreciative of UICC’s participation. I have engaged with UICC leadership and staff on institutional strengthening activities, conducted significant institutional analysis on UICC in the GT.CCC report, made recommendations to help strengthen the Board of Directors through developing country representation, and more broadly contributed to the strategy to increase general membership. Through my advocacy efforts and from my academic base, I have pushed forward UICC priorities, i.e. through joint work with GAPRI to reduce the cancer divide. I have actively participated in and drew leaders to the World Cancer Congress and the World Cancer Leaders’ Summit, as well as represented UICC at global meetings. I strategised with UICC around the UNHLM-NCD, including through NCD Child. I have promoted the dialogue between UICC, Mexican policy-makers and civil society organisations and helped organise and participated in the World Cancer Day event in Mexico with the Minister of Health.

Félicitations au Dr Jamal KHADER pour sa réélection au Board de l'UICC

Elections-UICC Jamal-Khader

BIOGRAPHY

Dr Jamal Khader is a consultant Radiation oncologist at King Hussein Cancer Center in Amman, Jordan. He is Director of the International Affairs Center and the Director of the Radiation oncology Residency programme, Head of the Lung Cancer Service, and serves on several institutional committees such as the Graduate Medical Education Committee. Dr Khader is a member of local, regional and international committees and associations. He is the Chairman of the scientific committee of the Jordanian OncologySociety, and member of the editorial board of the Pan Arab Oncology journal as well as a member in the Jordanian Chapter of the Mediterranean Task Force for Cancer Control.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

Serving as the Director of the International Affairs Center, I have extensive knowledge and network with top regional and international key players in cancer treatment and control. I am also heavily involved in training and education initiatives that work on providing opportunities for our staff in the International arena, as well as training programmes hosted at KHCC for local and regional cancer specialists.As UICC Board Member over the past couple of years I believe that UICC’s presence and impact in the Arab world is of significant importance and aligns well with UICCtargets.  I am proud to represent the Middle East in UICC and represent the UICC in the Middle East. I’m sure I will be able to encourage cancer health workers in this region of the world to be involved actively in different UICC activities.  UICC has significantlyimpacted professionals across the world in strengthening and providing opportunities for training and education.  Being a fellow of the UICC myself I feel it would be of value to work on training, education and fellowship and advocacyprogrammes.Over the past few years of my participation in different UICC activities including my current position as member of Board of Directors, I have been involved in adhoc committees such as fellowship and training committee, the World Cancer Declaration task force, a member of the membership committee beside active participation in the annual Cancer Summits and Board meetings.

Brésil: Dr. Maira CALEFFI

Elections-UICC Maira-Caleffi


BIOGRAPHY

MD and PhD. Dr Caleffi is Head of the Breast Centerat Hospital Moinhos de Vento and coordinator of Nucleo Mama Porto Alegre. She holds Pharmacy and Medicine degrees and a residency in Gynecology and Obstetrics. She completed her doctoral thesis at the University of London, and undertook postdoctoral studies in molecular biology in genetics and breast cancer at Vanderbilt University. Dr Caleffi is the founder and the olunteer President of IMAMA and FEMAMA. She is a member of The Brazilian Association of Palliative Care; Brazilian Breast Cancer Study Group (GBECAM); ASCO; Breast Health Global Initiative (BHGI); The Harvard School of Public Health - GTF.CCC; ISPOR; Unión Latinoamericana Contra el Cáncer de la Mujer (ULACCAM).

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

As a 20-year veteran in the breast cancer (BC) fight, my life as a doctor and as an individual has been guided by one vision: promote, maintain, educate and restore breast health and eradicate breast cancer as a life threatening disease. I founded IMAMA in 1993 to address the BC problem in my home state where we have the highest BC incidence and increasing mortality rates. FEMAMA, in 2006, was a consequence of the need for a national coalition (currently there are 53 NGOs). I alsostarted the ULACCAM with ACS and other Latin-American institutions. As a breastdedicated academic surgeon, I am involved in BC research projects for low and middleincome countries, improved risk factor and management models, and specialised technical training. International cooperation is needed to expand and share successfulexperiences with other countries not yet involved with UICC. I see the empowerment of patient groups as a key factor to successfully guarantee medical access and treatment in the future for underserved communities. Mutual cooperation and the need to strengthen our grass roots movements with the objective to reduce mortality rates are fundamental. My professional experience and my involvement with ASCO, BHGI, GTF, CCC, ISPORand the Brazilian NTCDs initiative allow me a unique view and insight into cancer issues. The tasks facing UICC in LMICs in the future are serious and challenging; we have to make cancer and its risk factors priorities in our governments' agendas. I am committed to UICC and to accomplishing this task.

Canada: Dr Heather BRYANT

Elections-UICC Heather-Bryant
BIOGRAPHY

Dr Bryant is a public health physician and epidemiologist whose career has focused on population-based cancer control. In 1990, at the Alberta Cancer Board, she implemented the firstpopulation-based breast screening programme in the province. As Vice President of Population Health and Information, she led the cancer registry, population-based research, active screening and prevention programmes, and implementation of the patient electronic health record. In 2008, she joined the Canadian Partnership Against Cancer as Vice President Cancer Control, and is implementing the Canadian cancer control strategy with partners throughout the country. She has chaired many national committees in cancer control, screening, and research.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

My work in cancer control has built partnerships with a wide range of stakeholders in cancer prevention, screening and care delivery systems – the public, policymakers, professionals, health agencies, and many others – and mobilising these teams to reach significant cancer control outcomes. In my current position with the CanadianPartnership Against Cancer (CPAC), a non-governmental agency mandated to implement the national cancer control strategy, it is critical to build relationships that allow us to synergize activity and accelerate progress, while recognising that the actual care and healthcare management decisions are made by our partners in their own jurisdictions. This is similar to the potential global role of the UICC, and thus I believe this experience will be of value. I have had several international roles, including membership on the Governing Council for the International Agency for Research on Cancer (IARC), as an executive member of the International Association of Cancer Registries (IACR) (contributing to the measurement of the global cancer burden), as a Board Member for the International Cancer Benchmarking Programmeme (an international analysis of survival and public attitudes towards cancer), and on a cancer control working group for the World Health Organisation (WHO). With the UICC, I have been a member of the Strategic Coordinating Committee (attending Board meetings), co-led the Prevention stream for the 2010 UICC Congress, and co-chaired the Scientific ProgrammeCommittee for the 2012 Congress. I look forward to assisting the UICC to develop significant global leadership in cancer control as a Board Member.